IAVI

Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Features

IAVI welcomes Germany to its list of generous supporters and recognizes the German government as a steadfast advocate and active participant in global health initiatives

July 6, 2023

Germany commits to 9.2 million Euros for the next five years to support development of a safe, effective, affordable, and accessible tuberculosis vaccine.

Read more

IAVI Report

Hitchhiking the mucosa

July 6, 2023

Brittany Hartwell and her lab are exploring new ways to transport vaccine antigens across mucosal barriers to trigger more protective immune responses against many pathogens, including HIV.

Read more

Features

IAVI announces first doses in new clinical trial of innovative HIV vaccine candidate

July 3, 2023

Sequential immunization approach used furthers IAVI’s HIV vaccine development.

Read more

Press Releases

IAVI launches multisite study with adolescent girls and young women to evaluate vaccine and antibody candidates for HIV prevention in sub-Saharan Africa

June 30, 2023

First participants for the Multisite Adolescent Girls and Young Women study screened at the Centre for Family Health Research in Zambia. IAVI has announced the enrolment of the first 29 participants for the Multisite Adolescent Girls and Young Women (MAGY) study at the Centre for Family Health Research in Zambia (CFHRZ). Over the next three…

Read more

Scientific Publications

Antigen pressure from two founder viruses induces multiple insertions at a single antibody position to generate broadly neutralizing HIV antibodies

Read more

Features

IAVI salutes commitments to TB vaccine R&D

June 29, 2023

Wellcome and Gates Foundation announce plans to fund a Phase III clinical trial of the tuberculosis vaccine candidate M72 in adults.

Read more

Press Releases

IAVI starts first-in-human Phase 1 clinical trial of single-dose Sudan virus vaccine candidate

June 27, 2023

NEW YORK – JUNE 27, 2023 – IAVI announced today that the first participants have been vaccinated with a Sudan virus (SUDV) vaccine candidate in a first-in-human Phase 1 clinical trial in the U.S. The IAVI-sponsored trial is funded by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness…

Read more

IAVI Report

Powering up African-based data centers

June 22, 2023

COVID-19 illustrated once again the importance of localized epidemiological data, monitoring, and analysis.

Read more